Characterization of AB154, a humanized, non-depleting alpha-TIGIT antibody undergoing clinical evaluation in subjects with advanced solid tumors

JOURNAL FOR IMMUNOTHERAPY OF CANCER(2019)

引用 2|浏览19
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要